Literature DB >> 24382084

Targeted therapy with eculizumab for inherited CD59 deficiency.

Britta Höchsmann1, Christian Dohna-Schwake, Henriette A Kyrieleis, Ulrich Pannicke, Hubert Schrezenmeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24382084     DOI： 10.1056/NEJMc1308104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

Review 1.  Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria.

Authors:  Samuel A Merrill; Robert A Brodsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

Review 3.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

Review 4.  Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.

Authors:  Tolulase Olutogun; Ilaria Cutini; Rosario Notaro; Lucio Luzzatto
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

5.  Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.

Authors:  Markus J Harder; Nadine Kuhn; Hubert Schrezenmeier; Britta Höchsmann; Inge von Zabern; Christof Weinstock; Thomas Simmet; Daniel Ricklin; John D Lambris; Arne Skerra; Markus Anliker; Christoph Q Schmidt
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

6.  Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene.

Authors:  Hani Boshra; Wioleta M Zelek; Timothy R Hughes; Santiago Rodriguez de Cordoba; B Paul Morgan
Journal:  J Immunol       Date:  2017-11-22       Impact factor: 5.422

7.  A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient.

Authors:  Markus Anliker; Inge von Zabern; Britta Höchsmann; Henriette Kyrieleis; Christian Dohna-Schwake; Willy A Flegel; Hubert Schrezenmeier; Christof Weinstock
Journal:  Transfusion       Date:  2014-01-03       Impact factor: 3.157

Review 8.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

9.  International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Authors:  J R Storry; L Castilho; Q Chen; G Daniels; G Denomme; W A Flegel; C Gassner; M de Haas; C Hyland; M Keller; C Lomas-Francis; J M Moulds; N Nogues; M L Olsson; T Peyrard; C E van der Schoot; Y Tani; N Thornton; F Wagner; S Wendel; C Westhoff; V Yahalom
Journal:  ISBT Sci Ser       Date:  2016-06-27

Review 10.  Protection of host cells by complement regulators.

Authors:  Christoph Q Schmidt; John D Lambris; Daniel Ricklin
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.